Inner Mongolia Zhongmu Biopharmaceutical Co., Ltd. announced that it will receive CNY 250,000,000 in equity round of funding on July 22, 2021. The transaction will include participation from existing investor China Animal Husbandry Industry Co., Ltd. (SHSE:600195). Upon closing, the registered capital of the company will increase from CNY 60,000,000 to CNY 310,000,000.

The transaction has been approved in the third interim meeting of the eighth session of the board of directors of the investor.